Literature DB >> 18279691

Vaginal distribution of Replens and K-Y Jelly using three imaging techniques.

Christine K Mauck1, David Katz, Erik P Sandefer, Marlina D Nasution, Marcus Henderson, George A Digenis, Irene Su, Richard Page, Kurt Barnhart.   

Abstract

BACKGROUND: Determination of vaginal distribution is important to the development of potential vaginal microbicidal or spermicidal products. STUDY
DESIGN: This was a descriptive study of three imaging techniques with a randomized crossover assignment of two gels and activity status within each technique.
METHOD: Each of three sites utilized one technique. Three nulligravid women and three parous women were to be enrolled at each site. We studied the effects of time, ambulation, parity and body mass index on vaginal spreading of two commonly used gels, K-Y Jelly and Replens. Imaging by magnetic resonance imaging and gamma scintigraphy was performed at 5, 20, 35 and 50 min after insertion of 3.5 mL of gel. Imaging with a fiberoptic probe was performed at 5 and 20 min after insertion.
RESULTS: Initial application of the gel resulted in approximately two thirds of maximum coverage possible, both in linear extent along the vaginal axis and in surface area covered. Over the next 45 min, spreading increased to about three quarters of the maximum possible. Ambulation generally increased linear spreading and the proportions of women with gel at the introitus and os. Effects of parity and body mass index (BMI) were similar on most measures of gel spreading, with nulligravid women tending toward greater spread than parous women and women of high BMI usually showing somewhat greater spread than women of normal weight. Differences between the two gels were not seen when all conditions of application were considered together.
CONCLUSION: In vivo imaging of gel distribution demonstrated that ambulation, parity and BMI affect vaginal gel spreading. The three imaging techniques have advantages and disadvantages and provide complementary information for microbicide development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279691     DOI: 10.1016/j.contraception.2007.11.016

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  15 in total

1.  Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Authors:  Alamelu Mahalingam; Eric Smith; Judit Fabian; Festo R Damian; Jennifer J Peters; Meredith R Clark; David R Friend; David F Katz; Patrick F Kiser
Journal:  Pharm Res       Date:  2010-09-15       Impact factor: 4.200

2.  Distribution of cell-free and cell-associated HIV surrogates in the female genital tract after simulated vaginal intercourse.

Authors:  Nicolette A Louissaint; Edward J Fuchs; Rahul P Bakshi; Sridhar Nimmagadda; Yong Du; Katarzyna J Macura; Karen E King; Richard Wahl; Arthur J Goldsmith; Brian Caffo; Ying Jun Cao; Jean Anderson; Craig W Hendrix
Journal:  J Infect Dis       Date:  2012-01-25       Impact factor: 5.226

3.  A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding.

Authors:  Andrew J Szeri; Su Chan Park; Stéphane Verguet; Aaron Weiss; David F Katz
Journal:  Phys Fluids (1994)       Date:  2008-08-21       Impact factor: 3.521

4.  Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels.

Authors:  Bonnie E Lai; Marcus H Henderson; Jennifer J Peters; David K Walmer; David F Katz
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

5.  Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus.

Authors:  Laura M Ensign; Benjamin C Tang; Ying-Ying Wang; Terence A Tse; Timothy Hoen; Richard Cone; Justin Hanes
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

6.  A Pilot Study Measuring the Distribution and Permeability of a Vaginal HIV Microbicide Gel Vehicle Using Magnetic Resonance Imaging, Single Photon Emission Computed Tomography/Computed Tomography, and a Radiolabeled Small Molecule.

Authors:  Edward J Fuchs; Jill L Schwartz; David R Friend; Jenell S Coleman; Craig W Hendrix
Journal:  AIDS Res Hum Retroviruses       Date:  2015-08-05       Impact factor: 2.205

7.  Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.

Authors:  Bonnie E Lai; Anthony R Geonnotti; Michael G Desoto; David C Montefiori; David F Katz
Journal:  Antiviral Res       Date:  2010-08-13       Impact factor: 5.970

8.  Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.

Authors:  Lara E Pereira; Tyana Singletary; Amy Martin; Chuong T Dinh; Frank Deyounks; Angela Holder; Janet McNicholl; Karen W Buckheit; Robert W Buckheit; Anthony Ham; David F Katz; James M Smith
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

9.  Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.

Authors:  Qingguo Xu; Laura M Ensign; Nicholas J Boylan; Arne Schön; Xiaoqun Gong; Jeh-Chang Yang; Nicholas W Lamb; Shutian Cai; Tao Yu; Ernesto Freire; Justin Hanes
Journal:  ACS Nano       Date:  2015-08-31       Impact factor: 15.881

10.  Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.

Authors:  Laura M Ensign; Timothy E Hoen; Katharina Maisel; Richard A Cone; Justin S Hanes
Journal:  Biomaterials       Date:  2013-06-13       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.